Lifecome Biochemistry Co.,Ltd.

Shenzhen Stock Exchange 002868.SZ

Lifecome Biochemistry Co.,Ltd. Gross Profit Margin for the year ending December 31, 2023: -20.66%

Lifecome Biochemistry Co.,Ltd. Gross Profit Margin is -20.66% for the year ending December 31, 2023, a -636.42% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Lifecome Biochemistry Co.,Ltd. Gross Profit Margin for the year ending December 31, 2022 was -2.81%, a -117.11% change year over year.
Lifecome Biochemistry Co.,Ltd. Gross Profit Margin for the year ending December 31, 2021 was 16.40%, a -45.97% change year over year.
Lifecome Biochemistry Co.,Ltd. Gross Profit Margin for the year ending December 31, 2020 was 30.35%, a -8.74% change year over year.
Lifecome Biochemistry Co.,Ltd. Gross Profit Margin for the year ending December 31, 2019 was 33.26%, a -3.70% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

Shenzhen Stock Exchange: 002868.SZ

Lifecome Biochemistry Co.,Ltd.

CEO	Mr. Zhongshou Bao
IPO Date	May 3, 2017
Location	China
Headquarters	No. 19,Nanpu Ecological Industrial Park
Employees	992
Sector	Consumers Staples
Industries Personal Care Biotechnology Cleaning Supplies Cosmetics Fertilizers Pet Food Pharmaceuticals Plastics

Description

Lifecome Biochemistry Co.,Ltd. operates as a biopharmaceutical company in China. It primarily offers bacitracin zinc products, colistin sulfate products, probiotics products, bacitracin methylene disalicylate products, biological preservatives, natamycin products, etc. The company was founded in 2003 and is based in Pucheng, China.

Key trends

Past 5 years